Johan Wedell-Wedellsborg

Insider Reports History

Location
Princeton, NJ
Signature
/s/ John LaRocca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Johan Wedell-Wedellsborg:

Company Role Class Num Shares Value Price $ Report Date Ownership
Y-mAbs Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 $0 $8.60 16 Sep 2025 By WG Biotech ApS
Y-mAbs Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 $0 $8.52 16 Sep 2025 Direct
Y-mAbs Therapeutics, Inc. Director, 10%+ Owner Employee Stock Option (right to buy) 0 16 Sep 2025 Direct

Insider Reports Filed by Johan Wedell-Wedellsborg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
YMAB Y-mAbs Therapeutics, Inc. 16 Sep 2025 12 -$39,259,499 4 Director, 10%+ Owner 18 Sep 2025, 21:03
YMAB Y-mAbs Therapeutics, Inc. 30 Jun 2025 2 $0 4 Director, 10%+ Owner 02 Jul 2025, 16:20
YMAB Y-mAbs Therapeutics, Inc. 11 Jun 2024 2 $0 4 Director, 10%+ Owner 13 Jun 2024, 21:01
YMAB Y-mAbs Therapeutics, Inc. 11 Dec 2023 1 +$44,232 4 Director 12 Dec 2023, 08:26
YMAB Y-mAbs Therapeutics, Inc. 07 Dec 2023 3 +$890,411 4 Director 11 Dec 2023, 17:25
YMAB Y-mAbs Therapeutics, Inc. 29 Nov 2023 1 +$309,477 4 Director 01 Dec 2023, 17:14
YMAB Y-mAbs Therapeutics, Inc. 27 Nov 2023 2 +$521,294 4 Director 29 Nov 2023, 17:15
YMAB Y-mAbs Therapeutics, Inc. 08 Jun 2023 2 $0 4 Director 09 Jun 2023, 18:04
YMAB Y-mAbs Therapeutics, Inc. 15 May 2023 1 +$981,404 4 Director 17 May 2023, 17:07
YMAB Y-mAbs Therapeutics, Inc. 15 Jul 2022 1 $0 4 Director 19 Jul 2022, 13:23
YMAB Y-mAbs Therapeutics, Inc. 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 17:05
YMAB Y-mAbs Therapeutics, Inc. 10 Jun 2021 1 -$405,971 4 Director 11 Jun 2021, 17:00
YMAB Y-mAbs Therapeutics, Inc. 08 Jun 2021 2 -$5,397,810 4 Director 10 Jun 2021, 18:35
YMAB Y-mAbs Therapeutics, Inc. 07 Jun 2021 1 -$2,472,583 4 Director 09 Jun 2021, 18:49
YMAB Y-mAbs Therapeutics, Inc. 03 Jun 2021 2 -$1,148,373 4 Director 07 Jun 2021, 16:31
YMAB Y-mAbs Therapeutics, Inc. 28 May 2021 2 -$1,152,648 4 Director 02 Jun 2021, 16:32